195 related articles for article (PubMed ID: 10428628)
1. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep.
Lightowlers MW; Jensen O; Fernandez E; Iriarte JA; Woollard DJ; Gauci CG; Jenkins DJ; Heath DD
Int J Parasitol; 1999 Apr; 29(4):531-4. PubMed ID: 10428628
[TBL] [Abstract][Full Text] [Related]
2. Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact.
Larrieu E; Mujica G; Gauci CG; Vizcaychipi K; Seleiman M; Herrero E; Labanchi JL; Araya D; Sepúlveda L; Grizmado C; Calabro A; Talmon G; Poggio TV; Crowley P; Cespedes G; Santillán G; García Cachau M; Lamberti R; Gino L; Donadeu M; Lightowlers MW
PLoS Negl Trop Dis; 2015; 9(10):e0004134. PubMed ID: 26517877
[TBL] [Abstract][Full Text] [Related]
3. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts.
Lightowlers MW; Heath DD
Parassitologia; 2004 Jun; 46(1-2):27-31. PubMed ID: 15305682
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby.
Barnes TS; Hinds LA; Jenkins DJ; Coleman GT; Colebrook AL; Kyngdon CT; Gauci CG; Lightowlers MW
Parasitology; 2009 Apr; 136(4):461-8. PubMed ID: 19195411
[TBL] [Abstract][Full Text] [Related]
5. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: 8 years of work.
Larrieu E; Mujica G; Araya D; Labanchi JL; Arezo M; Herrero E; Santillán G; Vizcaychipi K; Uchiumi L; Salvitti JC; Grizmado C; Calabro A; Talmon G; Sepulveda L; Galvan JM; Cabrera M; Seleiman M; Crowley P; Cespedes G; García Cachau M; Gino L; Molina L; Daffner J; Gauci CG; Donadeu M; Lightowlers MW
Acta Trop; 2019 Mar; 191():1-7. PubMed ID: 30576624
[TBL] [Abstract][Full Text] [Related]
6. Control of cystic echinococcosis in the Middle Atlas, Morocco: Field evaluation of the EG95 vaccine in sheep and cesticide treatment in dogs.
Amarir F; Rhalem A; Sadak A; Raes M; Oukessou M; Saadi A; Bouslikhane M; Gauci CG; Lightowlers MW; Kirschvink N; Marcotty T
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009253. PubMed ID: 33684115
[TBL] [Abstract][Full Text] [Related]
7. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes.
Woollard DJ; Gauci CG; Heath DD; Lightowlers MW
Vaccine; 2000 Oct; 19(4-5):498-507. PubMed ID: 11027814
[TBL] [Abstract][Full Text] [Related]
8. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
Heath DD; Koolaard J
Parasite Immunol; 2012 Jan; 34(1):40-4. PubMed ID: 22043983
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study.
Pourseif MM; Moghaddam G; Nematollahi A; Khordadmehr M; Naghili B; Dehghani J; Omidi Y
Acta Trop; 2021 Jun; 218():105883. PubMed ID: 33676937
[TBL] [Abstract][Full Text] [Related]
10. Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG95 vaccine.
Poggio TV; Jensen O; Mossello M; Iriarte J; Avila HG; Gertiser ML; Serafino JJ; Romero S; Echenique MA; Dominguez DE; Barrios JR; Heath D
Parasite Immunol; 2016 Aug; 38(8):496-502. PubMed ID: 27104482
[TBL] [Abstract][Full Text] [Related]
11. Hydatid disease: vaccinology and development of the EG95 recombinant vaccine.
Gauci C; Heath D; Chow C; Lightowlers MW
Expert Rev Vaccines; 2005 Feb; 4(1):103-12. PubMed ID: 15757477
[TBL] [Abstract][Full Text] [Related]
12. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
Alvarez Rojas CA; Gauci CG; Lightowlers MW
Parasite Immunol; 2013 Feb; 35(2):99-102. PubMed ID: 23009356
[TBL] [Abstract][Full Text] [Related]
13. Immunological responses and potency of the EG95NC
Jazouli M; Lightowlers MW; Bamouh Z; Gauci CG; Tadlaoui K; Ennaji MM; Elharrak M
Parasitol Int; 2020 Oct; 78():102149. PubMed ID: 32464256
[TBL] [Abstract][Full Text] [Related]
14. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere.
Zhang W; Li J; You H; Zhang Z; Turson G; Loukas A; McManus DP
Am J Trop Med Hyg; 2003 Jan; 68(1):40-3. PubMed ID: 12556145
[TBL] [Abstract][Full Text] [Related]
15. Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens.
Woollard DJ; Heath DD; Lightowlers MW
Parasitology; 2000 Aug; 121 ( Pt 2)():145-53. PubMed ID: 11085234
[TBL] [Abstract][Full Text] [Related]
16. Echinococcus granulosus: variability of the host-protective EG95 vaccine antigen in G6 and G7 genotypic variants.
Chow C; Gauci CG; Vural G; Jenkins DJ; Heath DD; Rosenzvit MC; Harandi MF; Lightowlers MW
Exp Parasitol; 2008 Aug; 119(4):499-505. PubMed ID: 18342311
[TBL] [Abstract][Full Text] [Related]
17. Epitope specificities and antibody responses to the EG95 hydatid vaccine.
Woollard DJ; Gauci CG; Heath DD; Lightowlers MW
Parasite Immunol; 1998 Nov; 20(11):535-40. PubMed ID: 9988310
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against hydatidosis using a defined recombinant antigen.
Lightowlers MW; Lawrence SB; Gauci CG; Young J; Ralston MJ; Maas D; Heath DD
Parasite Immunol; 1996 Sep; 18(9):457-62. PubMed ID: 9226681
[TBL] [Abstract][Full Text] [Related]
19. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy.
Scheerlinck JP; Casey G; McWaters P; Kelly J; Woollard D; Lightowlers MW; Tennent JM; Chaplin PJ
Vaccine; 2001 Jul; 19(28-29):4053-60. PubMed ID: 11427282
[TBL] [Abstract][Full Text] [Related]
20. Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus.
Dutton S; Fleming SB; Ueda N; Heath DD; Hibma MH; Mercer AA
Parasite Immunol; 2012 Jun; 34(6):312-7. PubMed ID: 22404504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
